534
Benito-Garagorri, Mereiter, Kirchner:
1
1
13C{ H} an d 31P{ H} NMR spectra were obtain ed at room tem perature (20 °C) on a Bruker
AVANCE-250 spectrom eter. Ch em ical sh ift data (δ, ppm ) are referen ced to SiMe4 an d H3PO4
1
(85%), respectively. Couplin g con stan ts, J, are given in Hz. 1H an d 13C{ H} NMR sign al as-
sign m en ts were con firm ed by 1H-COSY, 135-DEPT an d HMQC(1H-13C) experim en ts.
Syn th eses
2-[(N-Diphenylphosphino)amino]pyridine (PN-Ph) (1a). PPh 2Cl (9.5 m l, 53.1 m m ol) was
added dropwise to a solution of 2-am in opyridin e (5.0 g, 53.1 m m ol) an d trieth ylam in e
(7.4 m l, 53.1 m m ol) in toluen e (50 m l) at 0 °C. Th e m ixture was stirred at 80 °C for 3 h , fil-
tered an d th e solven t was rem oved un der vacuum to give 1a as a pale yellow solid. Yield
12.9 g (87%). 1H NMR (CDCl3): 7.93 (d, J = 4.6, 1 H, 6-Hpy); 7.51–7.42 (m , 5 H, Ph );
7.36–7.33 (m , 6 H, Ph an d 4-Hpy); 7.06 (d, J = 8.2, 1 H, 3-Hpy); 6.64 (dd, J = 5.2, 6.4, 1 H,
1
5-Hpy); 5.93 (d, J = 8.4, 1 H, NH). 13C{ H} NMR (CDCl3): 158.7 (d, J = 20.7, 2-Hpy); 148.1
(d, J = 1.5, 6-Hpy); 139.6 (d, J = 11.1, Ph 1); 137.82 (d, J = 2.3, 4-Hpy); 131.3 (d, J = 20.7,
1
Ph 2,6); 129.2 (Ph 4); 128.6 (d, J = 6.9, Ph 3,5); 115.0 (5-Hpy); 108.9 (d, J = 15.7, 3-Hpy). 31P{ H}
NMR (CDCl3): 27.5.
2-[(N-Diisopropylphosphino)amino]pyridine (PN-iPr) (1b). Th is ligan d h as been prepared an al-
ogously to 1a with PiPr2Cl (8.5 m l, 53.1 m m ol), trieth ylam in e (7.4 m l, 53.1 m m ol) an d
2-am in opyridin e (5.0 g, 53.1 m m ol) as th e startin g m aterials. Yield 10.6 g (95%). 1H NMR
(CDCl3): 8.00 (d, J = 3.9, 1 H, 6-Hpy); 7.42 (dt, J = 1.5, 2.0, 1 H, 4-Hpy); 7.08 (s, 1 H, 3-Hpy);
6.61 (m , 1 H, 5-Hpy); 4.94 (d, J = 10.5, 1 H, NH); 1.77 (m , J = 2.3, 7.0, 2 H, CH(CH3)2);
1
1.09–0.99 (m , 12 H, CH(CH3)2). 13C{ H} NMR (CDCl3): 160.7 (d, J = 19.6, 2-Hpy); 147.5 (d,
J = 1.2, 6-Hpy); 137.6 (d, J = 2.0, 4-Hpy); 114.1 (5-Hpy); 108.9 (d, J = 18.0, 3-Hpy); 26.3 (d,
1
J = 11.1, CH(CH3)2); 18.6 (d, J = 19.5, CH(CH3)2); 17.0 (d, J = 7.7, CH(CH3)2). 31P{ H} NMR
(CDCl3): 50.1.
2-[(2-Pyridyl)amino]dibenzo[d,f][1,3,2]dioxaphosphepine (PN-BIPOL) (1c). Th is ligan d h as been
prepared an alogously to 1a with biph en yl-2,2′-diyl ph osph oroch loridite (1.1 g, 4.3 m m ol),
trieth ylam in e (0.60 m l, 4.3 m m ol) an d 2-am in opyridin e (405 m g, 4.3 m m ol) as th e startin g
m aterials. Yield 1.2 g (92%). 1H NMR (CDCl3): 8.12 (d, J = 5.0, 1 H, 6-Hpy); 7.54–7.47 (m , 3 H,
Ph an d 4-Hpy); 7.39–7.24 (m , 6 H, Ph ); 6.84–6.79 (m , 2 H, 3-Hpy an d 5-Hpy); 6.38 (s, 1 H,
1
NH). 13C{ H} NMR (CDCl3): 155.4 (d, J = 16.9, 2-Hpy); 149.6 (d, J = 4.2, Ph ); 148.3 (6-Hpy);
138.0 (d, J = 1.6, 4-Hpy); 131.6 (d, J = 3.1, Ph ); 129.8 (d, J = 1.1, Ph ); 129.2 (Ph ); 125.3 (Ph );
1
122.2 (d, J = 1.5, Ph ); 116.6 (5-Hpy); 110.2 (d, J = 11.1, 3-Hpy). 31P{ H} NMR (CDCl3): 147.3.
Dimethyl (4S,5S)-2-[(2-pyridyl)amino]-1,3,2-dioxaphospholane-4,5-dicarboxylate (PN-TARMe
)
(1d ). Th is ligan d h as been prepared an alogously to 1a with dim eth yl (4S,5S)-2-ch loro-1,3,2-
dioxaph osph olan e-4,5-dicarboxylate (1.5 g, 6.1 m m ol), trieth ylam in e (0.85 m l, 6.1 m m ol)
an d 2-am in opyridin e (577 m g, 6.1 m m ol) as th e startin g m aterials. Yield 1.6 g (88%). 1H NMR
(CDCl3): 8.14 (d, J = 5.0, 1 H, 6-Hpy); 7.48 (m , 1 H, 4-Hpy); 6.80 (m , 1 H, 3-Hpy); 6.70 (d,
J = 8.2, 5-Hpy); 6.60 (s, 1 H, NH); 5.10 (dd, J = 1.6, 5.2, 1 H, CH); 4.84 (dd, J = 5.2, 10.0,
1
1 H, CH); 3.83 (s, 3 H, CH3); 3.81 (s, 3 H, CH3). 13C{ H} NMR (CDCl3): 171.4 (CO); 169.2
(CO); 155.7 (d, J = 20.0, 2-Hpy); 148.0 (6-Hpy); 140.0 (4-Hpy); 116.6 (5-Hpy); 110.3 (d, J =
1
6.9, 3-Hpy); 77.2 (CH); 77.0 (CH); 53.2 (CH3); 53.1 (CH3). 31P{ H} NMR (CDCl3): 142.6.
Collect. Czech. Chem. Commun. 2007, Vol. 72, No. 4, pp. 527–540